Homepage | Medicines Discovery Catapult

Innovation in medicine discovery science, to more rapidly benefit patients, lies at the heart of the strategy for the Medicines Discovery Catapult

Helping the drug discovery community deliver

Our CEO, Chris Molloy, attended the Delivering novel therapies in the 21st century meeting at The Royal Society from 24th – 25th October 2018. Here, he shares his key learnings from the event – and what they mean for drug discovery. Drug discovery is still failing too often: new treatment types are outdating the ‘white […]

Building an ecosystem to support data-driven health startups

The UK is in an excellent position to establish a world-leading position in the field of data-driven health. Technologies such as machine learning, computer vision, and neural networks will accelerate drug discovery by measuring and characterising target engagement, validating targets in translatable cell models, improving our understanding of drugs, disease and drug-target interactions within patients. […]

Writing a winning grant application

Bidding for grants and funding can be a very frustrating, tiresome and demoralising process. Hours can be wasted putting pen to paper, just so your dreams can be shattered months later after “so-called” experts and faceless bureaucrats tear your hard work apart. Of course, this is all part of the democratic process required to justify […]

On-demand sampling

The majority of biobank samples are collected as surgical excess, diagnostic remnants or post mortem tissue. While all of these sources are extremely valuable, they each have limitations. Surgical excess and diagnostic samples come from diseased patients, often cancer donors, and the closest to a ‘normal’ sample is adjacent tissue – that is, tissue obtained […]

"Putting the voice of patients at the heart of drug discovery is vital to develop the new targeted therapies of the future."

Chris Molloy, Chief Executive Officer

It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn

At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.

Partnership opportunities

Our position as an impartial not-for-profit organisation means we are uniquely placed to bring groups together from the private, public, academic and charitable sectors. We are able to offer these groups the facilities, expertise and tools that will ultimately make a real difference to the lives of patients. Organisations can also partner with us to help resolve particular short-term bottlenecks or problems including poor access to data and samples.

Find out more

We're recruiting

We’re now looking for talented scientists and technologists to join the Medicines Discovery Catapult team to help keep the UK at the forefront of medicines discovery. If you share our values and have the skills, drive and resilience to be part of an organisation looking to move the UK’s life sciences sector forward faster, we would be delighted to hear from you.

View our vacancies

Science & Technology

Informatics

Virtual R&D

Discovery Syndicates

Samples and Data